"By Ed Silverman @Pharmalot
March 31, 2020
Hello, everyone, and how are you coping this morning? We are doing just fine, thank you, as we continue to adjust to this new world. Although we have largely worked in the confines of the Pharmalot campus for the better part of more than a dozen years, we are also altering certain routines and, of course, relying more than ever on the latest whiz-bang technologies. Even so, some things just do not change — such as firing up the coffee kettle for a cup of stimulation. We remain stuck on maple bourbon, by the way. So pick up your own cup and join me as we dig in for another busy. Stay safe and stay in touch.
A vaccine that has been used to prevent tuberculosis is being given to health-care workers in Melbourne, Australia, to see if it will protect them against the novel coronavirus, Bloomberg News writes. The bacillus Calmette-Guerin, or BCG, shot has been used widely for about 100 years, with a growing appreciation for its off-target benefits. The World Health Organization says it’s important to know whether the BCG vaccine can reduce disease in those infected with the coronavirus, and is encouraging international groups to collaborate with a study.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis.
						Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
Pharmalot Columnist, Senior Writer
Ed covers the pharmaceutical industry.
pharmalittle
STAT Plus
Republish this article


By Ed Silverman
By Ed Silverman
advertisement
By Ed Silverman
By Elizabeth Cooney
By Ed Silverman
A roundup of STAT’s top stories of the day in science and medicine"
